← Leaderboards
Igor Kramnik
Harvard University (Sch Of Public Hlth)
$16,464,753
Attributed
$20,909,025
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,909,025 · 10
By mechanism
R01$17,399,710 · 5
UC7$1,589,791 · 3
R33$1,473,300 · 1
R21$446,224 · 1
Top collaborators
- William Ramses Bishai5 shared
- Michael Niederweis4 shared
Most similar at Harvard University (Sch Of Public Hlth)
Same institution · by research overlap
- Amitinder Kaur$35,271,713
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisPathogenLungPathway InteractionsIn VivoMacrophageInfectionIn VitroGranulomaTransmission ProcessMouse ModelPredispositionImmunocompetentLesionBaseGeneticResistanceCellsImmunityNecrosisMutantPreventPathogenesis
Grant awards (36)
Macrophage senescence as a driver of granuloma failure and progression to necrosis in TB and TB/HIV$3,145,850
R01 · FY2025 · AI
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies$688,810
R01 · FY2025 · HL · contact PI
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies$665,784
R01 · FY2024 · HL · contact PI
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies$695,103
R01 · FY2023 · HL · contact PI
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies$724,795
R01 · FY2022 · HL · contact PI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis$738,628
R01 · FY2019 · HL · contact PI
Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapies$716,257
R01 · FY2019 · HL · contact PI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis$738,628
R01 · FY2018 · HL · contact PI
Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapies$714,449
R01 · FY2018 · HL · contact PI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis$737,411
R01 · FY2017 · HL · contact PI
Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapies$711,270
R01 · FY2017 · HL · contact PI
Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy$491,100
R33 · FY2017 · AI · contact PI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis$753,536
R01 · FY2016 · HL · contact PI
Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapies$709,385
R01 · FY2016 · HL · contact PI
Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy$491,100
R33 · FY2016 · AI · contact PI
Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy$491,100
R33 · FY2015 · AI · contact PI
Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy$223,112
R21 · FY2014 · AI · contact PI
Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy$223,112
R21 · FY2013 · AI · contact PI
Aerobiology$72,885
UC7 · FY2013 · AI · contact PI
Aerobiology$1,373,806
UC7 · FY2012 · AI · contact PI
Genetics of Host Resistance and Susceptibillity to MTB$409,250
R01 · FY2012 · HL · contact PI
Genetics of Host Resistance and Susceptibillity to MTB$422,500
R01 · FY2011 · HL · contact PI
Aerobiology$143,100
UC7 · FY2011 · AI · contact PI
Genetics of Host Resistance and Susceptibillity to MTB$422,500
R01 · FY2010 · HL · contact PI
Genetics of Host Resistance and Susceptibillity to MTB$331,019
R01 · FY2009 · HL · contact PI
Genetics of Host Resistance and Susceptibillity to MTB$77,002
R01 · FY2009 · HL · contact PI
Genetics of Host Resistance & Susceptibility to TB$395,483
R01 · FY2006 · HL · contact PI
Genetics of Host Resistance &Susceptibility to TB$405,000
R01 · FY2005 · HL
New locus controlling suscept. to TB: genetics &funct.$404,500
R01 · FY2005 · AI
Genetics of Host Resistance &Susceptibility to TB$405,000
R01 · FY2004 · HL
New locus controlling suscept. to TB: genetics &funct.$404,500
R01 · FY2004 · AI
Genetics of Host Resistance &Susceptibility to TB$405,000
R01 · FY2003 · HL
New locus controlling suscept. to TB: genetics &funct.$404,500
R01 · FY2003 · AI
Genetics of Host Resistance &Susceptibility to TB$405,000
R01 · FY2002 · HL
New locus controlling suscept. to TB: genetics &funct.$404,500
R01 · FY2002 · AI
Genetic susceptibility to Mycobacterium tuberculosis$364,050
R01 · FY2001 · AI